v3.26.1
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) - USD ($)
$ in Thousands
 3 Months Ended 12 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Dec. 31, 2025
Cash flows from operating activities:      
Net income $ 17,860 $ 31,036  
Adjustments to reconcile net income to net cash provided by operating activities:      
Depreciation and amortization 68,681 70,529  
Equity compensation expense 5,890 6,978  
Amortization of debt issuance costs 2,963 3,133  
Non-cash lease expense 3,260 2,555  
Provision for credit losses 1,169 0 $ 1,032
Inventory reserve 0 123  
Loss on sale of assets 1,261 9,211  
Amortization of interest rate swap 0 2,426  
Deferred tax provision 2,709 7,016  
Loss on extinguishment of debt 36,512 0  
Changes in operating assets and liabilities      
Accounts receivable (41,945) (23)  
Inventories (2,396) 3,416  
Contract assets (2,535) (12,313)  
Prepaid expenses and other current assets 1,604 (1,235)  
Accounts payable (38) 2,182  
Accrued and other liabilities (22,916) (16,258)  
Contract liabilities (2,092) 5,913  
Other assets 1,195 (361)  
Net cash provided by operating activities 71,182 114,328  
Cash flows from investing activities:      
Purchase of property, plant and equipment (118,370) (77,553)  
Proceeds from sale of assets 3,467 9,376  
Net cash used for investing activities (114,903) (68,177)  
Cash flows from financing activities:      
Borrowings on debt instruments 1,353,857 347,491  
Payments on debt instruments (1,147,272) (344,204)  
Principal payments on other borrowings (395) (1,950)  
Payment of debt issuance cost (12,958) 0  
Principal payments on finance leases (593) (719)  
Dividends paid to stockholders (42,604) (36,445)  
Repurchase of common shares 0 (9,956)  
Cash paid for shares withheld to cover taxes (14,979) (2,827)  
Net effect on deferred taxes and taxes payable related to the vesting of restricted stock 0 16  
Distributions to noncontrolling interest (151) (357)  
Net cash provided by (used for) financing activities 134,905 (48,951)  
Net increase (decrease) in cash and cash equivalents 91,184 (2,800)  
Cash and cash equivalents - beginning of period 3,179 4,750 4,750
Cash and cash equivalents - end of period 94,363 1,950 $ 3,179
Supplemental cash disclosures:      
Cash paid for interest 41,349 57,330  
Cash paid for taxes 54 486  
Supplemental disclosure of non-cash investing activities:      
(Increase) decrease in accrued capital expenditures 6,485 (14,089)  
Supplemental disclosure of non-cash financing activities:      
Fair value changes in interest rate swap (1,914) 7,314  
Accrued debt issuance cost $ (1,349) $ 0